Affordable Immunity - World Class Quality - Current Technology

With the new vaccine plant going into commercial production from March 2006 in phases,IIL will make India self sufficient in modern vaccines and also help India emerge as a leading vaccine manufacturer in the world.

IIL 's R&D efforts are directed at developing new technologies in biologicals and vaccines. IIL in collaboration with Indian Institute of Science, Bangalore is developing the world 's first DNA Rabies vaccine under the Prime Minister "Jai Vigyan Programme ".IIL is also involved in developing vaccines for various tropical diseases which are of no interest to western countries but very relevant for a country like India.IIL spends about 5%of its sales (Rs 830 mio in 2004-05) on research.

IIL has research collaborations with several reputed national and international institutes. Some of our research collaborators...

1. Indian Institute of Science -DNA vaccines, Hepatitis B
   
   

2. Indian Veterinary Research Institute -PPR Vaccine
   
   

3. Institute of Cytology and Preventive Oncology - HPV vaccine
   
   

4. Centre for Disease Control (CDC),USA - Hepatitis A, Rabies
   
   

5. National Institute of Health (NIH),USA - Vaccinia vectors
   
   

6. Institute of Molecular Biology and Applied Ecology, Germany - Plant vaccines
   
   

7. Thomas Jefferson Medical School, USA - Monoclonal antibodies
   
   

8. Harvard Medical School, USA - Polysaccharide Vaccines
   
   

9. Institute of Animal Health, UK - FMD Epidemiology
   
   

10. Veterinary Technologies Corporation,USA - Brucellosis Vaccine
    
    

11. International Vaccine Institute, Korea - Vaccines for GI infections and Japanese Encephalitis.
    
    

12. Onderstepoort Veterinary Institute,South Africa - FMD antigens
    
    

13. Centre Hospitalier Universitaire Vaudois, Switzerland - HPV oral vaccine
    

----------------------------------------------------------------------------------------